HER2 Signaling in Breast Cancer Treatment (Q167950): Difference between revisions
From geokb
(Changed label, description and/or aliases in en, and other parts: modified description with assistance from Llama 3.1) |
(Changed an Item: moved OpenAlex ID to its dedicated external ID datatype for consistency) |
||
| Property / same as | |||
| Property / same as: https://openalex.org/T10755 / rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: T10755 / rank | |||
Normal rank | |||
Revision as of 12:25, 8 September 2024
HER2 signaling in breast cancer treatment, focusing on targeted therapies like trastuzumab.
- HER2
- breast cancer
- trastuzumab
- EGFR
- monoclonal antibody
- chemotherapy
- metastatic
- receptor tyrosine kinases
- neuregulin 1
- ADAM metalloproteinases
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HER2 Signaling in Breast Cancer Treatment |
HER2 signaling in breast cancer treatment, focusing on targeted therapies like trastuzumab. |
|
